The U.S. Food and Drug Administration’s (FDA) chief counsel, Hilary Perkins, has resigned from the role just two days after her appointment, she said on March 13.
“Unfortunately, my work at the Department of Justice defending the FDA throughout multiple administrations—which I performed consistent with my oath to zealously advocate on behalf of the United States—created an unnecessary distraction from advancing the Administration’s priorities. With great respect for the career attorneys and professionals at FDA and with deep appreciation for my family, friends, and colleagues who have stood by me during this challenging time, I have resigned as Chief Counsel,” Perkins said.
“Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,” the FDA said without providing further details.
According to her LinkedIn profile, Perkins first joined the Department of Justice’s (DOJ) consumer protection division as a trial attorney in 2019, during President Donald Trump’s first administration. She became assistant director in 2020, a position she held until March of this year.
Before her work at the DOJ, Perkins was employed as an associate at a Washington-based law firm and as a law clerk to Judge Rhesa H. Barksdale on the U.S. Court of Appeals for the Fifth Circuit.
“I can’t imagine anyone who would be more at odds with President Trump’s agenda,” Hawley wrote.
Makary, President Donald Trump’s nominee for FDA Commissioner, has yet to be confirmed by the Senate for the FDA’s top role, and it is unclear what, if any, role he played in Perkins’ appointment.
The Epoch Times reached out to the Makary and the FDA for comment but did not receive a response by publication time.